A CDMO with a rich heritage

Our company began its journey back in 2001 with the management buyout of a solid dose facility in UK, including a portfolio of around 20 well-known pharmaceutical products. 

An innovative strategy

It took a few years for Moldons to develop its current strategy. In 2002, the pharmaceutical industry was prospering from the many profitable products it had developed during the 1980s and cost saving measures, such as outsourcing, had not yet become a priority.

Moldons Pharmaceuticals UK was among the first pharmaceutical company in the UK to certify its entire operations, and an extensive environmental policy gave the company a competitive edge and strong values. This environmental profile remains an important part of Moldons Pharmaceuticals UK today and our customers appreciate the benefits of working with a CDMO that guarantees high sustainability standards.